Who we are

BioCurate is a bold, collaborative venture, dedicated to translating Australian medical research and delivering health and economic benefits to the world. Created jointly by two of Australia’s leading biomedical universities, the University of Melbourne and Monash University, we are operationally independent with an absolute commitment to rigorous science and partnering closely with researchers to help conquer the challenges which stand between great ideas and global impact. We can help you change the future.

We bridge the gap

Our collaborative team of global biomedical experts bridge the gap between:

Academia + Industry
Ideas + Impact
Discovery + Partnerships
Collaboration + Commercialisation
Research + Translation

What we are doing

Staff profiles

Our team

Has over 150 years of combined biotech/pharma industry experience

Has been directly involved in over 35 Investigational New Drug applications (INDs)

Are responsible for 70 therapeutics currently in the clinic

Were directly involved in 15 deals worth a cumulative total of over $2.1 billion

Twitter feed

BioCurate is excited to announce that Dr Damien Bates has been appointed CEO of BioCurate. This is more positive news for BioCurate and provides the crucial skills, continuity and leadership essential for ongoing success.

“Greatly honoured to receive @BioCurate 'Proof of Concept' funding to advance research on targeted treatments for #breastcancer in collaboration with Prof Yeesim Khew-Goodall @CCB_Research @UniMelbMDHS @SciMelb

The second award under BioCurate’s new Proof of Concept fund has been granted to Prof Michael Parker from @Bio21Institute, in collaboration with Prof Yeesim Khew-Goodall from @CCB_Research. Read more https://bit.ly/3BD9l7E

BioCurate sponsored second prize at the @ASCEPTanz Student Forum Symposium, which was won by @Ranita_Histac from @UNSW for her presentation "A population pharmacokinetic model to inform tacrolimus therapy in heart transplant recipients." Congratulations to all the winners!